Caspase-3 is a prototypical group II effector caspase that can be activated by both the receptor and mitochondria-mediated pathways. Mice deficient in caspase-3 (caspase-3 −/−) have defective ...

The following is a summary of "Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer ...

PODO Therapeutics will showcase two poster presentations highlighting its innovative platform at the upcoming AACR Annual ...